417 related articles for article (PubMed ID: 22414189)
1. Headache currents commentary.
Peatfield R
Headache; 2012 Apr; 52(4):715. PubMed ID: 22414189
[TBL] [Abstract][Full Text] [Related]
2. What happens to the old headache medicines?
Rapoport AM
Headache; 2012 Apr; 52(4):701-6. PubMed ID: 22486742
[TBL] [Abstract][Full Text] [Related]
3. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Dahlöf C; Maassen Van Den Brink A
Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
[TBL] [Abstract][Full Text] [Related]
4. Ergotamine and dihydroergotamine: a review.
Bigal ME; Tepper SJ
Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
[TBL] [Abstract][Full Text] [Related]
5. The 5-HT
Whealy M; Becker WJ
Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644
[TBL] [Abstract][Full Text] [Related]
6. [The problems of migraine headache treatment].
Vilionskis A; Vaitkus A
Medicina (Kaunas); 2002; 38(7):679-84. PubMed ID: 12474651
[TBL] [Abstract][Full Text] [Related]
7. Acute treatment of migraine attacks.
Ferrari MD; Haan J
Curr Opin Neurol; 1995 Jun; 8(3):237-42. PubMed ID: 7551126
[TBL] [Abstract][Full Text] [Related]
8. Antimigraine drugs.
Diener HC; Kaube H; Limmroth V
J Neurol; 1999 Jul; 246(7):515-9. PubMed ID: 10463349
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy of headache with special reference to migraine].
Beubler E
Wien Med Wochenschr; 1994; 144(5-6):100-1. PubMed ID: 8053212
[TBL] [Abstract][Full Text] [Related]
10. Ergotamine, dihydroergotamine: current uses and problems.
Tfelt-Hansen P
Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275
[TBL] [Abstract][Full Text] [Related]
11. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
Scott AK
Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
[TBL] [Abstract][Full Text] [Related]
12. Migraine.
Edmeads JG
CMAJ; 1988 Jan; 138(2):107-13. PubMed ID: 2891428
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of headache].
Cavanna M
Clin Ter; 1989 Apr; 129(2):135-7. PubMed ID: 2525999
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of migraine].
Titus F
Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
[No Abstract] [Full Text] [Related]
15. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
[TBL] [Abstract][Full Text] [Related]
16. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of the acute migraine attack].
Titus F
Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Zhang L; Hay JW
CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
[TBL] [Abstract][Full Text] [Related]
20. [Serotonin agonists and antagonists in migraine].
Ollat H
Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
